Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Wuhan University · Zhongnan Hospital of Wuhan University
Abstract
In December 2019, novel coronavirus (SARS-CoV-2) pneumonia (COVID-19) was reported in Wuhan and has since rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19.
The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed.
Citation impact
- FWCI
- 28.03
- Percentile
- 100%
- References
- 26
Authors
10- FWFan Wang
Wuhan University, Zhongnan Hospital of Wuhan University
- JNJiayan Nie
Wuhan University, Zhongnan Hospital of Wuhan University
- HWHaizhou Wang
Wuhan University, Zhongnan Hospital of Wuhan University
- QZQiu Zhao
Wuhan University, Zhongnan Hospital of Wuhan University
- YXYong Xiong
Wuhan University, Zhongnan Hospital of Wuhan University
Topics & keywords
- CD8
- Pneumonia
- Coronavirus disease 2019 (COVID-19)
- Flow cytometry
- Immunology
- Lymphocyte
- Medicine
- Peripheral